In a previous study of biomarkers in dengue and chikungunya neuroinvasive conditions, CXCL-10 in the CSF presented a 156.5 pg/mL cut-off with 91.7% sensitivity and specificity for the diagnosis of these conditions [25]. Here, CXCL10 is linked to dengue disease.